Danofloxacin mesylateDanofloxacin mesylate
MedChemExpress (MCE)
HY-B0501
119478-55-6
CP 76136-27
99.87%
4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months
-20°C, 1 month (sealed storage, away from moisture)
Room temperature in continental US
may vary elsewhere.
Danofloxacin mesylate (CP 76136-27) is a fluoroquinolone used as a veterinary drug. Danofloxacin mesylate has a broad spectrum of bactericidal activity, mainly inhibiting the DNA cycloenzyme of the bacteria. In addition, Danofloxacin mesylate is a substrate for ATP-dependent efflux transporters (P-gp and MRP2).
Danofloxacin mesylate (1-25 μM
1 h) transport across Caco-2 cells is asymmetric, with a rate of secretion exceeding that of absorption[1]. Danofloxacin mesylate (18 h) inhibits bovine bacterial respiratory pathogens with the MIC90 of 0.06-0.125 μg/mL for Pasteurella hemolyticus, Pasteurella multocida and Haemophilus somnosus[2].
Pharmacokinetic Analysis in geese[3] Route Dose (mg/kg) (Non-salt dose) AUC(0-t) (μg·h/mL) AUC(0-inf) (μg·h/mL) kel (1/h) ka (1/h) k10 (1/h) k21 (1/h) k12 (1/h) t1/2kel (h) Cmax (μg/mL) Tmax (h) Cl (mL/g·h) V1 (mL/g) V2 (mL/g) F % i.v. 5 14.27 15.35 0.10 / 0.25 1.14 1.34 6.61 / / 0.35 1.46 1.71 / p.o. 5 8.30 9.14 0.17 0.32 / / / 4.12 0.96 1.70 / / / 57.95
| | | |
| | | | | |
[1]. Schrickx JA, et al. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters. Br J Pharmacol. 2007 Feb
150(4):463-9. [Content Brief]
[2]. Giles, C.J., et al., Clinical pharmacokinetics of parenterally administered danofloxacin in cattle. J Vet Pharmacol Ther, 1991. 14(4): p. 400-10. [Content Brief]
[3]. Sartini I, et al. Danofloxacin pharmacokinetics and tissue residues in Bilgorajska geese. Res Vet Sci. 2021 May
136:11-17. [Content Brief]